BACKGROUND: Silver nanoparticles have been shown to exhibit promising cytoprotective activities towards HIV-infected T-cells; however, the effects of these nanoparticles towards other kinds of viruses remain largely unexplored. The aim of the present study was to investigate the effects of silver nanoparticles on hepatitis B virus (HBV). METHODS: Monodisperse silver nanoparticles with mean particle diameters…
Antiviral Therapy Template
Write in a clean editor, then format for Antiviral Therapy in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Antiviral Therapy format
Antiviral Therapy is a peer-reviewed journal published by SAGE, covering HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Antiviral Therapy, 12(3), pp. 45–58.
Formats any DOI in Antiviral Therapy style. No sign-up. |
| Publishes research in | HIV/AIDS drug development and treatment HIV Research and Treatment Hepatitis C virus research HIV-related health complications and treatments HIV/AIDS Research and Interventions |
| ISSN | 1359-6535 |
| Citation impact (2-yr) | 1.94 |
| h-index | 103 |
| i10-index | 1,687 |
| Total citations | 71,758 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | www.intmedpress.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Antiviral Therapy per year
Citation impact of Antiviral Therapy by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Antiviral Therapy
BACKGROUND: The effects of convalescent plasma (CP) infusion, one of the treatment options for severe Middle East respiratory syndrome coronavirus (MERS-CoV) infections, have not yet been evaluated. METHODS: Serological responses of CP-infused MERS patients during the 2015 Korean MERS outbreak at a tertiary care centre were evaluated. Serological activity was evaluated with anti-MERS-CoV enzyme-linked immunosorbent…
SARS-CoV, human coronavirus NL63 (HCoV-NL63) and HCoV-HKU1 were first described in 2003, 2004 and 2005 respectively. Nevertheless, discovery of three new human coronaviruses does not necessary represent a sudden increase in emerging infections by new coronaviruses. Only SARS-CoV has recently been introduced to the human population; the other two have been circulating in humans for…
To assess the relation between resistance to antiretroviral drugs for treatment of HIV-1 infection and virological response to therapy, results from 12 different studies were re-analysed according to a standard data analysis plan. These studies included nine clinical trials and three observational cohorts. The primary end-point in our analyses was virological failure by week 24.…
BACKGROUND: The World Health Organization (WHO) HIV drug resistance (HIVDR) threshold survey method was developed for surveillance of transmitted HIVDR in resource-limited countries. The method is being implemented with minimal resources as a routine public health activity to produce comparable results in multiple countries and areas within countries. Transmitted drug resistant HIV strains will be…